Focal ischemia enhances the adverse effect potential of N-methyl-d-aspartate receptor antagonists in rats
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction.
1986 • 588 citations
Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?
1994 • 217 citations
Safety and Tolerability of the Glutamate Antagonist CGS 19755 (Selfotel) in Patients With Acute Ischemic Stroke
1995 • 206 citations
The excitatory amino acid antagonist d-CPP-ene (SDZ EAA-494) in patients with epilepsy
1993 • 194 citations
Brain edema and cerebrovascular permeability during cerebral ischemia in rats.
1990 • 176 citations
The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems
1992 • 170 citations
The NMDA Receptor, NMDA Antagonists and Epilepsy Therapy
1992 • 165 citations
Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats
1992 • 122 citations
Basic aspects of epilepsy.
1993 • 77 citations
Strategies for Neuroprotection with Glutamate Antagonists
1995 • 61 citations
Medical Therapy for Ischemic Stroke
1996 • 51 citations
Autoradiographic analysis of 3H-MK-801 (dizocilpine) in vivo uptake and in vitro binding after focal cerebral ischemia in the rat
1992 • 34 citations
Functional evidence for PCP-like effects of the anti-stroke candidate MK-801
1988 • 22 citations
Safety, Tolerability and Pharmacokinetics of the N‐Methyl‐<scp>d</scp>‐Aspartate Antagonist Ro‐01–6794/706 in Patients with Acute Ischemic Strokeab
1995 • 12 citations